Pharmacological and histopathological characterization of Bothrops lanceolatus (Fer de lance) venom-induced edema

Inflammation Research

Volumn 53, Issue 7, 2004, Pages 284-291

  Guimaraes A Q ^a   Cruz Hofling M A ^a   Ferreira De Araujo P M ^a   Bon, A ^b   Lobo De Araujo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b INSTITUT PASTEUR   (France)

Author keywords

Amines; B. lanceolatus venom; Bradykinin; Inflammation; Metalloproteinases; Phospholipase A2; Rat paw edema; Vascular permeability

Indexed keywords

ARACHIDONIC ACID; BRADYKININ; DEXAMETHASONE; EDETIC ACID; HISTAMINE; ICATIBANT; INDOMETACIN; MEPYRAMINE; METHYSERGIDE; SEROTONIN; SNAKE VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIALYSIS; EDEMA; HISTOLOGY; HISTOPATHOLOGY; LEUKOCYTE ACTIVATION; MALE; MOLECULAR WEIGHT; NEUTROPHIL; NONHUMAN; PAW EDEMA; PERITONEUM MAST CELL; PLETHYSMOGRAPHY; RAT; TIME;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIEMETICS; ARACHIDONIC ACID; BOTHROPS; BRADYKININ; CARDIOVASCULAR AGENTS; CROTALID VENOMS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; EDETIC ACID; EXTREMITIES; HISTAMINE; HISTAMINE H1 ANTAGONISTS; INDOMETHACIN; MAST CELLS; METHYSERGIDE; PYRILAMINE; RATS; RATS, WISTAR; SEROTONIN; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 3242769075     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Rosenfeld G. Symptomatology, pathology and treatment of snake bites in South America. In: Bücherl W, Buckley EE, editors Venomous Animals and their Venoms, New York: Academic Press, Vol. 52, 1971: 345-403.
2. Bolaños R. Las serpientes venenosas de Centroamerica y el problema del ofidismo. Primeira parte. Aspectos zoologicos, epidemiologicos y biomédicos. Rev Cost Cienc Med 1982; 3: 165-84.
3. Lôbo de Araújo A, Souza AO, Cruz-Höfling MA, Flores CA, Bon C. Bothrops lanceolatus (Fer de lance) venom induces edema formation and increases vascular permeability in the mouse hind paw. Toxicon 2000; 38: 209-21.
4. Nahas L, Denson KWE, Macfarlane RG. A study of the coagulant action of eight snake venoms. Thromb Diath Haemorrh 1964; 12: 355-67.
5. Nahas L, Kamiguti AS, Barros MAR. Thrombin-like and factor X-activator components of Bothrops snake venoms. Thromb Haemost 1979; 41: 314-28.
6. Kouyoumdjian JA, Polizelli C, Lobo SM, Guimarães SM. Fatal extradural haematoma after snake bite (Bothrops moojeni). Trans R Soc Trop Med Hyg 1991; 85: 552.
7. Boer-Lima PA, Gontijo JAR, Cruz-Höfling MA. Histologic and functional renal alterations caused by Bothrops moojeni snake venom in rats. Am J Trop Med Hyg 1999; 61: 698-706.
8. Ohsaka A. Hemorrhagic, necrotizing and edema-forming effects of snake venoms. In: Lee CY, editor. Snake Venoms. Handbook of Experimental Pharmacology, Vol. 52, Berlin: Springer-Verlag, 1979: 480-546.
9. Bjarnasson JB, Fox JW. Hemorrhagic metalloproteinases from snake venoms. Pharmacol Ther 1994; 62: 325-37.
10. Kamiguti A, Hay CRM, Theakston RGD, Zuzel M. Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases. Toxicon 1996; 34: 627-42.
11. Gutiérrez JM, Rucavado A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie 2000; 82: 841-5.
12. 2 homologue from Bothrops neuwiedi pauloensis venom. Arch Biochem Biophys 2000; 378: 201-9.
13. 2 isolated from the venom of the snake Bothrops asper (terciopelo). Toxicon 1998; 36: 1861-9.
14. 2 purified from Trimeresurus mucrosquamatus snake venom. Toxicon 1989; 27: 115-25.
15. 2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon 1987; 25: 501-15.
16. Condrea E. Hemolytic effects of snake venoms. In: Lee CY, editor. Snake Venoms. Handbook of Experimental Pharmacology, Vol 52, Berlin: Springer-Verlag, 1979: 448-54.
17. Lôbo de Araújo A, Donato JL, Bon C. Purification from Bothrops lanceolatus (Fer de lance) venom of a fibrino(geno)lytic enzyme with esterolytic activity. Toxicon 1998; 36: 745-58.
18. Lôbo de Araújo A, Kamiguti A, Bon C. Coagulant and anticoagulant activities of Bothrops lanceolatus (Fer de lance) venom. Toxicon 2001; 39: 371-5.
19. Maruyama M, Sugiki M, Yoshida E, Mihara H, Nakajima N. Purification of two fibrinolytic enzymes from Bothrops jararaca venom. Toxicon 1992; 30: 853-64.
20. Borkow G, Gutiérrez JM, Ovadia M. Isolation and characterization of synergistic hemorrhagins from the venom of the snake Bothrops asper. Toxicon 1993; 31: 1137-50.
21. Francischi A, Rucavado A, Mora N, Gutiérrez JM. Purification and characterization of BaH4, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Toxicon 2000; 38: 63-77.
22. Bjarnasson JB, Tu AT. Hemorrhagic toxins from diamondback rattlesnake (Crotalus atrox) venom: isolation and characterization of five toxins and the role of zinc in hemorrhagic toxin e. Biochemistry 1978; 17: 3395-404.
23. Friederich C, Tu AT. Role of metals in snake venoms for hemorrhagic, esterase and proteolytic activities. Biochem Pharmacol 1971; 29: 1549-56.
24. Ownby CL, Tu AT. Chemical neutralization of snake venoms. In: Tu AT, editor. Venoms - Chemistry and Molecular Biology. New York: John Wiley and Sons, 1977: 435-56.
25. Thomas L, Tyburn B and the Research Group on Snake Bite in Martinique. Bothrops lanceolatus bites in Martinique: clinical aspects and treatment. In: Bon C, Goyffon M, editors. Envenomings and their Treatments. Lyon: Fondation Marcel Mérieux, 1996: 255-65.
26. Thomas L, Tyburn B, Bucher B, Pecout F, Ketterle D, Rieux D et al. Prevention of thrombosis in human patients with Bothrops lanceolatus envenoming in Martinique: failure of anticoagulants and efficacy of a monospecific antivenom. Am J Trop Med Hyg 1995; 52: 419-26.
27. 2 from Bothrops lanceolatus (Fer de lance) venom: molecular and enzymatic properties. Toxicon 1994; 32: 1069-81.
28. Bogarín G, Romero M, Rojas G, Lutsch C, Casadamont M, Lang J et al. Neutralization by a monospecific Bothrops lanceolatus antivenom, of toxic activities induced by homologous and heterologous Bothrops snake venoms. Toxicon 1999; 37: 551-7.
29. Faria L, Antunes E, Bon C, Lôbo de Araújo A. Pharmacological characterization of the rat paw edema induced by Bothrops lanceolatus (Fer de lance) venom. Toxicon 2001; 39: 825-30.
30. Soares de Moura R, Aguiar AS, Melgarejo AR, Carvalho LCRM. Pharmacological aspects of mouse hind paw edema induced by Lachesis muta rhombeata venom. Toxicon 1998; 36: 771-80.
31. Enerback L, Svensson I. Isolation of rat peritoneal mast cells by centrifugation on density gradients of Percoll. J Immunol Meth 1980; 39: 135-45.
32. Shore PA, Burkhalter A, Cohen-Jr VH. A method for the fluorometric assay of histamine in tissues, J Pharmacol Exp Ther, 1959; 127: 182-6.
33. Chaves F, Barboza M, Gutiérrez JM. Pharmacological study of edema induced by venom of the snake Bothrops asper (terciopelo) in mice. Toxicon 1995; 33: 31-9.
34. Giraldelo CMM, Zappellini A, Muscará MN, De Luca IMS, Hyslop S, Cirino G et al. Effects of arginine analogues on rat hind paw oedema and mast cell activation in vitro. Eur J Pharmacol 1994; 257: 87-93.
35. Esquisatto LC, Costa SK, Camargo EA, Ribela MT, Brain SD, de Nucci G et al. The plasma protein extravasation induced by adenosine and its analogues in the rat dorsal skin: evidence for the involvement of capsaicin sensitive primary afferent neurones and mast cells. Br J Pharmacol 2001; 134: 108-15.
36. Rao TS, Currie JL, Shaffer AF, Isakson PC. Comparative evaluation of arachidonic acid (AA) and tetradecanoylphorbol acetate (TPA) induced dermal inflammation. Inflammation 1993; 17: 723-41.
37. Costa SKP, Moreno-Jr H, De Nucci G, Antunes E. The effect of Phoneutria nigriventer (armed spider) venom on arterial blood pressure of anaesthetised rats. Eur J Pharmacology 1996; 298: 113-20.
38. Siegel S. Estatística Não Paramétrica. McGraw Hill do Brasil tda., Rio de Janeiro 1979; 302-5.
39. Selistre HS, Queiroz LS, Cunha OAB, De Souza GEP, Giglio JR. Isolation and characterization of hemorrhagic, myonecrotic and edema-inducing toxins from Bothrops insularis (jararaca ilhoa) snake venom. Toxicon 1990; 28: 261-73.
40. 2, one of the hemorrhagic factors in the venom of Bothrops jararaca. In: Ohsaka A, Hayashi K, Sawai Y, editors. Animal, Plant and Microbial Toxins. Vol 1. New York: Plenum Press 1976; 111-21.
41. Assakura MT, Reichl AP, Mandelbaum FR. Comparison of the immunological, biochemical and biophysical properties of three hemorrhagic factors isolated from the venom of Bothrops jararaca (jararaca). Toxicon 1986; 24: 943-6.
42. 2 myotoxins from Bothrops lanceolatus snake venoms. Toxicon 1995; 33: 1405-24.
43. Francischi JN, Dias MF, Rocha OA, de Abreu MS, Kiyomi Funauama Tatsuo MA, Farinelli P et al. Pharmacological characterization of Sephadex-induced oedema in rat paws: predominant role of serotonin and platelet-activating factor. Int Arch Allergy Immunol 1993; 109: 398-406.
44. Kamiguti AS, Zuzel M, Theakston RDG. Snake venom metalloproteinases and disintegrins: interactions with cells. Braz J Med Biol Res 1998; 31: 853-62.
45. Antunes E, Mariano M, Cirino G, Levi S, de Nucci G. Pharmacological characterization of polycation-induced rat hind paw edema. Br J Pharmacol 1990; 101: 986-90.
46. Trebien HA., Calixto J.B. Pharmacological evaluation of rat oedema induced by Bothrops jararaca venom. Agents Actions 1989; 26: 292-300.
47. Perales J, Amorin CZ, Rocha SLG, Domont GB, Moussatché H. Neutralization of oedematogenic activity of Bothrops jararaca venom on the mouse paw by an antibothropic fraction isolated from opossum (Didelphis marsupialis) serum. Agents Actions 1992; 37: 250-9.
48. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol Rev 1992; 44: 4-80.
49. 1 activity isolated from the black bellied hornet (Vespa basilis) venom. Toxicon 1993; 32: 605-13.
50. Erd F, Trk K, Arnyi P, Szekely JI. A new assay for antiphlogistic activity: zymosan-induced mouse ear inflammation. Agents Actions 1993; 39: 137-42.
51. 2. In: Schelmer RP, Clamor HN, Oronsky AL, editors. Antiinflammatory Steroid Action Basic and Clinical Aspects. New York: Academic Press, 1989; 48-66.
52. Angeli A, Masera RG, Sartori ML, Fortunati N, Racca S, Dovio A et al. Modulation by cytokines of glucocorticoid action. Ann NY Acad Sci 1999; 876: 210-20.
53. Tailor A, Tomlinson A, Salas A, Panes J, Granger DN, Flower RJ et al. Dexamethasone inhibition of leucocyte adhesion to rat mesenteric postcapillary venules: role of intercellular adhesion molecule 1 and KC Gut. 1999; 45: 705-12.
54. Katori M, Oda T, Nagai K. A site of action of dexamethasone on leukocyte extravasation in microcirculation. Agents Actions 1990; 29: 24-6.
55. Farsky SHP, Walber J, Costa-Cruz M, Cury Y, Teixeira CFP. Leukocyte response induced by Bothrops jararaca crude venom: in vivo and in vitro studies. Toxicon 1997; 35: 185-93.
56. Gutiérrez JM, Chaves F, Gerdas L. Inflammatory infiltrate in skeletal muscle injected with Bothrops asper venom. Rev Biol Trop 1986; 34: 209-19.
57. Lomonte B, Tarkowsky A, Hanson LA. Host response to Bothrops asper snake venom, analysis of edema formation, inflammatory cells and cytokine release in a mouse model. Inflammation 1993; 17: 93-105.